Provided by Tiger Trade Technology Pte. Ltd.

CEL-SCI Corp

2.06
+0.270015.08%
Post-market: 2.100.0401+1.95%19:20 EDT
Volume:478.99K
Turnover:958.99K
Market Cap:36.23M
PE:-0.80
High:2.09
Open:1.80
Low:1.78
Close:1.79
52wk High:10.83
52wk Low:0.8900
Shares:17.59M
Float Shares:16.85M
Volume Ratio:5.15
T/O Rate:2.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5688
EPS(LYR):-6.2655
ROE:-252.53%
ROA:-66.82%
PB:3.31
PE(LYR):-0.33

Loading ...

Banco Santander Brasil Advances Exchange Offer Process With Key CVM and SEC Filings

TIPRANKS
·
Sep 22

Braskem’s New Controller Wins CVM Approval for Full Share Tender Offer

TIPRANKS
·
Sep 21

CVM Clears Braskem Tender Offer After Change of Control

TIPRANKS
·
Sep 21

T4F Leaves B3 as CVM Approves Transition to Private Company

TIPRANKS
·
Sep 02

Acoramidis Demonstrates Reversal of Cardiac Structural Disease Progression and Functional Decline and Significantly Increases Days Alive and Free from Hospitalization in ATTR-CM

GlobeNewswire
·
Aug 30

SCI CEO Geert Kersten Acquires 100,000 Common Shares Valued at $138,000

Reuters
·
Aug 26

Norway's Zelluna ASA Reports Q2 Loss

Reuters
·
Aug 20

Accuray Q4 Revenue Falls as Tariff Concerns, Geopolitical Tensions Weigh on Demand

Reuters
·
Aug 20

Sweden's Cantargia Narrows H1 Loss, Raises SEK 132 Mln

Reuters
·
Aug 19

Germany's Immatics Q2 Revenue Rises but Misses Estimates

Reuters
·
Aug 18

SCI Shareholders Elect Directors at Annual Meeting

Reuters
·
Aug 17

CEL-SCI Q3 EPS $(0.47) Up From $(1.36) YoY

Benzinga Earnings
·
Aug 17

Cancer Immunotherapy Developer CEL-SCI's Q3 Net Loss Unchanged

Reuters
·
Aug 17

SCI FY26 Q3 Net Loss Narrows to USD 5.7 Million; Loss Per Share Improves to USD 0.47

Reuters
·
Aug 17

SCI Corporation Q2 EPS USD -0.47

THOMSON REUTERS
·
Aug 17

SCI Corporation Q2 Net Income USD -5.7 Million

THOMSON REUTERS
·
Aug 17

Press Release: CEL-SCI Reports Fiscal Third Quarter 2026 Results

Dow Jones
·
Aug 17

Press Release: Gerdau S.A. - Consolidated Information

Dow Jones
·
Aug 05

CEL-SCI announces publication of study supporting multikine biomarker strategy

TIPRANKS
·
Aug 04

SCI Study in Oral Oncology Flags Low PD-L1, N0 Oral Cancer Patients for Multikine Survival Benefit

Reuters
·
Aug 04